Presentation is loading. Please wait.

Presentation is loading. Please wait.

Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis  Philippe-Jean Bousquet, MD, Christophe Combescure, PhD,

Published byHerman Sasmita Modified over 5 years ago

Similar presentations

Presentation on theme: "Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis  Philippe-Jean Bousquet, MD, Christophe Combescure, PhD,"— Presentation transcript:

1 Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis 
Philippe-Jean Bousquet, MD, Christophe Combescure, PhD, Jean-Michel Klossek, MD, Jean-Pierre Daurès, MD, Jean Bousquet, MD  Journal of Allergy and Clinical Immunology  Volume 123, Issue 6, Pages (June 2009) DOI: /j.jaci Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Flow chart. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Cumulative distribution of VAS score changes depending on RQLQ score and RTSS4 changes. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig 3 ROC curves (left) and cost function (right) evaluating VAS score evolution depending on clinical improvement. 1, No clinical improvement versus a clinical improvement in RQLQ score, RTSS4, or both. 2, No clinical improvement or clinical improvement in RQLQ score or RTSS4 versus clinical improvement in both RQLQ score and RTSS4. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis  Philippe-Jean Bousquet, MD, Christophe Combescure, PhD,"

Similar presentations

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Pharmacologic rationale for treating allergic and nonallergic rhinitis

Pharmacologic rationale for treating allergic and nonallergic rhinitis
Fatty acids, inflammation, and asthma

Fatty acids, inflammation, and asthma
Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5– grass pollen tablet for seasonal allergic rhinitis  Alain Didier, MD,

Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5– grass pollen tablet for seasonal allergic rhinitis  Alain Didier, MD,
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Ann-Marie M. Schoos, MD, PhD, Jacob D

Ann-Marie M. Schoos, MD, PhD, Jacob D
Disparities in allergic disease: Hypersensitivity and social disorders

Disparities in allergic disease: Hypersensitivity and social disorders
Complementary and Alternative Medicine in Allergy-Immunology: More Information is Needed  Leonard Bielory, MD  The Journal of Allergy and Clinical Immunology:

Complementary and Alternative Medicine in Allergy-Immunology: More Information is Needed  Leonard Bielory, MD  The Journal of Allergy and Clinical Immunology:
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial  Marko Kalliomäki, MD, PhD,

Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial  Marko Kalliomäki, MD, PhD,
Desensitization to Chemotherapeutic Agents

Desensitization to Chemotherapeutic Agents
Preventive effect of nasal filters on allergic rhinitis: A randomized, double-blind, placebo- controlled crossover park study  Peter Kenney, BSc, Ole Hilberg,

Preventive effect of nasal filters on allergic rhinitis: A randomized, double-blind, placebo- controlled crossover park study  Peter Kenney, BSc, Ole Hilberg,
Intramuscular Versus Intravenous Immunoglobulin Replacement Therapy and Measurement of Immunoglobulin Levels During Immunoglobulin Replacement Therapy 

Intramuscular Versus Intravenous Immunoglobulin Replacement Therapy and Measurement of Immunoglobulin Levels During Immunoglobulin Replacement Therapy 
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Children with allergic and nonallergic rhinitis have a similar risk of asthma  Bo Lund Krogsgaard Chawes, MD, Klaus Bønnelykke, MD, PhD, Eskil Kreiner-Møller,

Children with allergic and nonallergic rhinitis have a similar risk of asthma  Bo Lund Krogsgaard Chawes, MD, Klaus Bønnelykke, MD, PhD, Eskil Kreiner-Møller,
Fatty acids, inflammation, and asthma

Fatty acids, inflammation, and asthma
Airway hyperresponsiveness to mannitol and methacholine and exhaled nitric oxide: A random-sample population study  Asger Sverrild, MD, Celeste Porsbjerg,

Airway hyperresponsiveness to mannitol and methacholine and exhaled nitric oxide: A random-sample population study  Asger Sverrild, MD, Celeste Porsbjerg,
Keith J. Simons, PhD, Margherita Strolin Benedetti, PhD, F. Estelle R

Keith J. Simons, PhD, Margherita Strolin Benedetti, PhD, F. Estelle R
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J

Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J

Similar presentations

Ads by Google